Lanzamiento Enero 2027

Ensayo controlado aleatorizado1999

The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females

Kamimori GH, Joubert A, Otterstetter R, Santaromana M, Eddington ND

European journal of clinical pharmacology · 29 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
U.S. Department of Defense
Gobierno
U.S. Army Medical Research and Development Command

Según 2 financiadores declarados.

Publicación

Publicado
1999-08-09 · Eur J Clin Pharmacol · vol. 55 · número 6 · págs. 445–449
Editorial
Springer Science+Business Media
Citado
49 citas · más que el 14% de estudios similares · 0.0× el promedio de su campo
Referencias
14 trabajos
Acceso
De pago
Áreas de investigación
Coffee research and impacts · Pharmacogenetics and Drug Metabolism · Menopause: Health Impacts and Treatments
Palabras clave
caffeine, menstrual cycle, pharmacokinetics, estrogen, progesterone, follicular phase, ovulatory phase, luteal phase, estradiol, plasma caffeine concentration, drug clearance, healthy women
MeSH
humans, caffeine, central nervous system stimulants, cross-over studies, menstrual cycle, follicular phase, luteal phase, ovulation, adult, female

5 autores

  • Gary H. Kamimori🇺🇸University of Maryland, Baltimore; Walter Reed Army Institute of Research
  • A. Joubert🇺🇸University of Maryland, Baltimore
  • Ronald Otterstetter🇺🇸Walter Reed Army Institute of Research
  • M. Santaromana🇺🇸Walter Reed Army Institute of Research
  • Natalie D. Eddington🇺🇸University of Maryland, Baltimore

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

Hormonal fluctuations of estrogen and progesterone in eumenorrheic women may be capable of altering the pharmacokinetics of certain agents. The objective of this study was to determine the effect of the luteal, ovulatory and follicular phases of the menstrual cycle on the pharmacokinetics of caffeine, a low clearance, flow-independent drug.

Methods

Subjects were ten healthy, non-smoking, eumenorrheic females who were not pregnant and had not used oral contraceptives for a minimum of 3 months prior to the study. Blood samples were collected during one menstrual cycle for the determination of estradiol and progesterone concentrations during the follicular (days 2-6 post-onset of menses), ovulatory (days 13-16 post-onset of menses) and luteal (days 22-26 post-onset of menses) phases. Caffeine was administered over a single menstrual cycle during the follicular, ovulatory and luteal phases. Each subject was administered a single oral dose of caffeine (300 mg) in 100 ml of lemonade during each phase of the menstrual cycle. A venous catheter was used to collect blood samples at pre-dose and at the following time points: 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10, 12 and 24 h. Plasma caffeine concentrations were determined using a validated ultraviolet high-performance liquid chromatography method.

Results

There were no significant (P < 0.05) differences in the pharmacokinetic parameters of caffeine across the menstrual cycle phases. The average area under the plasma concentration-time curve (AUCinf) was 93.01 mg 1(-1) x h and the absorption rate constant (ka) was 2.88 h(-1) during the ovulatory phase, 83.0 mg 1(-1) h and 2.06 h(-1), respectively, during the luteal phase and 84.7 mg 1(-1) x h and 1.84 h(-1), respectively, during the follicular phase.

Conclusions

These findings suggest that the menstrual cycle does not significantly alter the pharmacokinetics of caffeine.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.